Pharmaceuticals Analyst Schott and SMid Cap Biotech Analysts Cheng & Romero, along with Dr. Axelrad, Director of Clinical Research in Inflammatory Bowel Disease (IBD) Center at NYU, (relevant companies ABBV, JNJ, MRK, PFE, ROIV, MCRB) discuss IBD and C. Diff Infection on an Analyst/Industry conference call to be held on April 24 at 11 am. Webcast Link
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on ABBV:
